VIMAC's investing model is founded on two core principlesâ€”respect for the entrepreneur, and humble acceptance that nobody has seen the future. New business creation is essentially a collaborative enterprise where success requires continuous learning and broad-based sharing of innovative ideas.  Based in Boston, they deploy capital in early-stage companies located in the eastern U.S. and Canada. Today, they have two separate investment teamsâ€”one focused on early stage ventures in IT/Adv.Materials technologies and the other focused on life sciences.  To date, VIMAC investments have led to the creation of over 20 successful companies that continue to generate business innovations in IT, communications, and Internet technologies. These investments today account for over $2 billion in market value. The fund seeks to make about five new investments each year. A new investment typically goes into a Series A or Series B round with adequate reserves to support subsequent funding until the company exits via a trade sale or an IPO. Over its lifetime, a company is likely to receive $5 million to $15 million from the fund. The life sciences team makes investments from the VIMAC Milestone Medica in early stage biotechnology and medical device companies.  They lead or co-lead most investments and their managers play a very active role on portfolio companiesâ€™ Boards of Directors. Often, they invest in a company's first institutional round of funding and maintain support throughout the companyâ€™s lifecycle. Along the way, they maintain a close working relationship with the management team, helping them refine business plan, build go-to-market strategies, enhance capital efficiency, find early customers and partners, and grow the business.

Vimac Ventures

Mount Royal Ventures is a private investment firm that focuses on early stage companies.

Mount Royal Ventures

NewSpring Capital is a private equity firm that seeks to invest in business services, enterprise and infrastructure technology, security, and business intelligence sectors.

NewSpring

Escalate Capital Partners is a leading mezzanine firm focused exclusively on providing capital to venture-backed expansion and late-stage companies within technology, life sciences and service based industries. The Escalate team combines experience in venture capital and commercial finance to deliver a broad array of senior, subordinated and mezzanine debt solutions that are less dilutive than equity and provide more flexibility than conventional debt from banks or asset-based lenders.  As a company expands operations on a path to profitability, it should also look to broaden sources of capital beyond equity and traditional debt to achieve an optimal blend between overall cost and capital flexibility. Escalate's facilities are tailored to finance permanent working capital requirements, acquisitions and buy outs.  Escalate can also structure syndicated transactions incorporating equity and debt through an extensive network of venture capital and debt financing partners.  As a private debt fund with over $495 million in cumulative capital commitments, Escalate offers patient, stable capital tailored to each company’s unique needs. The Escalate investment team has 80+ years of combined experience and has invested more than $2 billion in over 500 companies.

Escalate Capital Partners

Merck Global Health Innovation Fund (Merck GHI) is evolving corporate healthcare venture capital globally by utilizing their healthcare ecosystem strategy.  This investment strategy connects innovative companies with complementary technologies to develop integrated healthcare solutions.  Merck GHI has $500M under management and provides growth capital to emerging healthcare technology companies worldwide while leveraging the vast R&D-based, global resources of Merck.  With a vision that data will be the currency in healthcare, GHI invests broadly in digital health.  GHI invests in platform companies with proven technologies or business models where Merck's expertise and perspectives can accelerate revenue growth and enhance value creation.   Since late 2010, Merck GHI has made over 20 investments in Digital Health companies.

Merck Global Health Innovation Fund

Hamilton Lane is a private markets investment firm that serves institutional and private wealth investors worldwide. As of December 31, 2022, Hamilton Lane had $831.9 billion in assets under management and supervision, with $107.5 billion in discretionary assets and $724.4 billion in non-discretionary assets. Hamilton Lane specializes in developing adaptable investment programs that give clients access to a broad range of private market strategies, sectors, and geographies.

Hamilton Lane

WAVE Equity Partners (WAVE) is an independent sustainability-focused private investment firm. We partner with early-growth companies whose proven clean technologies drive meaningful bottom-line impact and environmental benefits for large industrial manufacturers. Our industry knowledge and dedication to true partnership allow us to work effectively with leaders whose innovative solutions are commercially accepted, deliver immediate impact and are poised to scale. WAVE is currently investing out of its third institutional fund and has approximately $420 million under management (AUM) as of Dec. 31, 2022. For more information please visit https://waveep.com/.

WAVE Equity Partners

Peloton Equity is a private equity firm providing growth capital to innovative healthcare companies.

Peloton Equity

At Flexstone Partners, they take a truly different approach to private investments. Clients can take advantage of private equity, real estate, private debt, and infrastructure solutions, specific expertise in the hard-to-access small- and mid-cap market, and an unparalleled level of personalized service.

Flexstone Partners

AeroSafe Global

Empowering efficiency, visibility and collaboration throughout supply networks

Supply Chain Tech

TagNtrack is a tech company that specializes in advanced asset tracking and management solutions. The company offers a platform called “RELATIVITY,” which integrates with RFID and IoT technologies, providing real-time visibility and traceability of shipments and valuable assets. Apart from location tracking, the solution harnesses the power of smart sensors to provide its users with real-time information about the asset’s physical condition, including temperature/humidity, acceleration, pressure, tampering, and light. It is also capable of delivering business intelligence in the form of dashboards, custom reporting, alerts, rules engine, and advanced analytics to supply chain and asset management operations of organizations. The company's platform and solutions primarily target multi-model logistics, packaging, and manufacturing industries and are designed to easily integrate with existing ERP, warehouse management systems, transportation management systems, and manufacturing line vision systems. Funding and financials In January 2022, the company raised USD 10 million in Series A funding led by Dell Technologies Capital. The round also saw the participation of Merck Global Innovation Fund and Aerosafe Global Inc. The proceeds were intended to expand the company’s operations and business reach.

Making cold chains faster, smarter, and cooler.

Cold Chain Innovation

<div>
 
 TagNTrac is an IoT platform that provides integrating multimode technologies typically hardware, software, and data to build solutions.
 
</div>

TagNTrac is an IoT platform that provides integrating multimode technologies typically hardware, software, and data to build solutions.

AeroSafe Global develops and produces aerogels and related materials for temperature-sensitive shipping needs in the United States. Its products are used in various thermal insulation applications to transport biomedical, pharmaceutical, and other temperature-sensitive products. The company provides a reliable, simple, and sustainable temperature sensitive supply chain solutions to the world’s leading biopharma companies. AeroSafe Global delivers cold-chain services for the biopharma industry that results in zero temperature excursions for every client, every product, every time. With proprietary packaging, logistics, and operational services, the company builds customized solutions that ensure the safe delivery of temperature-sensitive biopharmaceuticals.

AeroSafe Global recognized for triple-digit growth

Companies providing cold chain storage solutions, such as refrigerated facilities and warehouses for the secure storage of temperature-sensitive goods

Companies offering technologies to track and maintain precise temperature conditions throughout the entire supply chain, such as IoT sensors and temperature monitoring devices

Companies that design and produce packaging solutions to safeguard the integrity of temperature-sensitive products during transport

Companies that facilitate the safe and controlled movement of temperature-sensitive goods from one location to another, employing specialized equipment and logistics

Companies that provide technology-driven solutions to optimize and manage parts or all of the cold chain process

AeroSafe Global

Featured Industries

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless